Newsroom | 8846 results

MURFREESBORO, Tenn.--(BUSINESS WIRE)--National HealthCare Corporation (NYSE American: NHC), the nation’s oldest publicly traded long-term health care company, announced today that it will pay a quarterly dividend of 64 cents per common share to shareholders of record on June 30, 2025 and payable on August 1, 2025. This represents a 4.9% increase over last quarter’s regular common dividend. Forward-Looking Statements Statements in this press release that are not historical facts are forward-look...

SAN JOSE, Calif.--(BUSINESS WIRE)--Verifyle, a leader in secure messaging, file sharing and information exchange, today announced a partnership with the National Behavioral Health Association of Providers (NBHAP). NBHAP is a leading and unifying voice of addiction-focused treatment programs, providing education and advocacy for those in the behavioral health and addiction treatment industries. Verifyle has been chosen to provide ultra-secure document sharing, messaging and digital signatures te...

FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in the BofA Securities 2025 Health Care Conference, May 13-15, 2025, in Las Vegas, Nevada. In connection with the conference, there will be an online webcast of the Company’s presentation available on the Company’s website starting at 1:20 p.m. Central Time / 11:20 a.m. Pacific Time on Wednesday, May 14th, 2025. The live webcast of the presentation will be available...

PEMBROKE, Bermuda--(BUSINESS WIRE)--Timed to the start of Mental Health Awareness Month, AXIS Capital Holdings Limited (“AXIS Capital” or the “Company”) (NYSE: AXS) partnered with The Harris Poll to survey the state of mental health within the insurance profession. The research findings revealed a number of trends pointing to widespread and rising stress and anxiety; a desire for better mental health support; and a belief that insurance trails other industries in prioritizing mental health init...

BIRMINGHAM, Ala.--(BUSINESS WIRE)--For the second consecutive year, leading correctional healthcare company NaphCare, Inc., and the NaphCare Charitable Foundation, Inc. (NCF), are recognizing Mental Health Awareness Month through the “Reframing Mental Health” initiative – a patient-centered art exhibit and advocacy campaign. Reframing Mental Health encourages patients to express their experiences navigating mental illness through art, shedding light on the realities of daily challenges, inner r...

BOSTON--(BUSINESS WIRE)--Sonde and Saaya partner to bring voice-based mental health tracking and support to blue-collar workforces across energy, manufacturing, and logistics....

VICTORIA, British Columbia--(BUSINESS WIRE)--Following a successful pilot phase, mental health tech company, HiBoop, is launching the beta stage of its assessment platform to the broader market. Designed to streamline mental health support, the platform is now available to clinics and healthcare providers across Canada for early access. The beta launch builds on strong early adoption and positive feedback from pilot users. “The pilot proved that there’s a real need for HiBoop, and it works,” sa...

LOS ANGELES--(BUSINESS WIRE)--In recognition of Mental Health Awareness Month, Rula Health, a national behavioral healthcare provider group that delivers high-quality mental healthcare covered by insurance, has released its inaugural “2025 State of Mental Health Report: Mental Well-being in a Changing World”. Based on responses from more than 2,000 adults across the U.S., the new report sheds light on the emotional toll of modern life, the reasons people are seeking mental healthcare, how they’...

BOSTON--(BUSINESS WIRE)--OM1: What: OM1, the leader in real-world data and AI-driven insights in mental health for life sciences, announced an upcoming poster presentation hosted by Jessica Probst, OM1’s Principal, Real World Evidence. The poster focuses on the linkage between Glucagon-like Peptide 1 Receptor Agonists (GLP-1s) and Suicidal Ideation (SI). Consistent with other findings and despite warnings on the label, there was no significant increase in SI prevalence after GLP-1 initiation. W...

TORONTO--(BUSINESS WIRE)--Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry platform company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, today announced that the United States Patent and Trademark Office has granted U.S. patent 12,291,499 in support of its CYB003 program in MDD. The patent, which is expected to provide exclusivity until 2041, includes cla...